Senior Investigator Profile

First NameDavid
Award StatusTerm 2
Current PostIGA Professor of Ophthalmology for Glaucoma and Allied Studies
Telephone020 7566 2059/76086813
InstitutionMoorfields Eye Hospital NHS Foundation Trust
NHS TrustMoorfields Eye Hospital NHS Foundation Trust
Region NameLondon
Primary Research FieldOphthalmology
Secondary Research FieldNeurosciences
BiographyDavid Garway-Heath is International Glaucoma Association Professor of Ophthalmology for Glaucoma & Allied Studies at University College London (UCL), Hon. Consultant Ophthalmologsist at Moorfields Eye Hospital, and Theme Leader for Vision Assessment & Imaging at the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital and UCL Institute of Ophthalmology. An important aspect of his research is the refinement of clinical trial design and Glaucoma progression measurement. The outcomes of the landmark multi-centre UK Glaucoma Treatment Study which he conducted were recently published in The Lancet. For the first time, these findings provide solid evidence that the most commonly prescribed eye drop for glaucoma more than halves vision loss after 2 years of treatment compared with placebo. Furthermore, the results showed that it was possible to reduce considerably the period needed to identify treatment effects, which increases the likelihood of bringing new drugs more quickly and more cost-effectively to patients. Another focus of Professor Garway-Heath’s research is the development of new tools and the refinement of existing tools to improve the diagnosis and follow-up of Glaucoma. The Moorfields Motion Displacement Test, a new laptop-based visual field test developed under his supervision, was awarded in 2008 the MRC Overall Translational Research Innovation Award encompassing all medical fields. In the field of imaging, the Moorfields Regression Analysis, a software that he developed for one of the earliest commercially available imaging devices, is now being used worldwide and has become a ‘reference standard’ for establishing the performance of other imaging devices. He also has made important contributions to the understanding of the structure–function relationship in Glaucoma and the map that he invented, also known as ‘Garway-Heath Map’, is being used widely in research in this field and has been incorporated into diagnostic software by leading manufacturers. David Garway-Heath has published over 170 peer-reviewed research papers, and has been recipient of the prestigious Alcon Research Institute Award, the World Glaucoma Association (WGA) Senior Clinician Scientist Research Recognition Award, the NIHR Senior Investigator Award and an NHS Clinical Excellence Award. He has also been made Fellow of the Research in Vision and Ophthalmology (ARVO). Professor Garway-Heath is Vice President of the European Glaucoma Society (EGS), Vice President of the Imaging and Perimetry Society, Chair of the EGS Committee on Healthcare Quality & Patient Outcome Measures, Co-Chair of the EGS Scientific Committee, Co-chair of the World Glaucoma Association Consensus Committee, past Chair of the UK & Eire Glaucoma Society and past Chair of the Glaucoma Section Program Committee of the Association for Research in Vision and Ophthalmology. He sits on the HTA Clinical Evaluation and Trials Board and is on the editorial board of several international peer-reviewed journals.

View CV 

<< Search SI Directory